Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Summary

The purpose of this research study is to test the effectiveness of three treatment arms that are designed to improve survival in patients with non-small cell lung cancer. Eligible subjects could be randomized to four (4) cycles of chemotherapy followed by immunotherapy, or immunotherapy followed by chemotherapy, or four cycles of chemotherapy plus immunotherapy.

Timeline

Start

2016-09-13

Primary completion

2021-11-19

Completion

2021-11-19

Drugs

Indications